论文部分内容阅读
目的:探索无创通气联合法舒地尔治疗老年肺心病伴呼吸衰竭患者的价值,以期为临床实践提供借鉴。方法:以我院接治的60例老年肺心病伴呼吸衰竭患者作为本次研究对象,按照治疗方法的不同将其随机分为观察组与对照组,对比两组患者治疗期间的疗效、肺动脉收缩压以及血浆BNP值得变化。结果:经统计发现,观察组总有效率为86.7%,明显优于对照组56.7%的总有效率,两组差异显著(P<0.05),具有统计学意义。结论:无创通气联合法舒地尔在治疗老年肺心病伴呼吸衰竭患者中能够显著改善患者的肺通气功能,降低患者肺动脉收缩压,同时改善患者血浆BNP水平,提高患者心肺功能和患者身体状况,在实践中值得推广应用。
Objective: To explore the value of non-invasive ventilation combined with Fasudil in the treatment of elderly patients with pulmonary heart disease and respiratory failure, in order to provide reference for clinical practice. Methods: Sixty elder patients with pulmonary heart disease and respiratory failure who were treated in our hospital were selected as the study subjects. They were randomly divided into observation group and control group according to different treatment methods. The curative effect and pulmonary artery contraction Pressure and plasma BNP values change. Results: According to the statistics, the total effective rate in the observation group was 86.7%, which was significantly better than that in the control group (56.7%). There was significant difference between the two groups (P <0.05). Conclusion: Noninvasive ventilation combined with fasudil can significantly improve pulmonary ventilation in patients with senile pulmonary heart disease and respiratory failure, reduce pulmonary artery systolic pressure, improve plasma BNP level and improve cardiopulmonary function and patient physical status, In practice it is worth promoting.